On June 11, 2024, Hospital Santa Maria della Pietà in Nola, Southern Italy, announced the establishment of the first robotic cardiac heart program in the region. The hospital is now successfully undergoing robotic ablation procedures on patients with heart rhythm disorders using cutting-edge Genesis Robotic Magnetic Navigation (RMN) system. This technology provides an unprecedented level of precision and control for electrophysiologists, allowing them to target arrhythmias with unmatched accuracy while minimizing risk to patients.
Dr. Mario Volpicelli, Head of the Electrophysiology Unit at the hospital, expressed their primary goal of improving patients’ lives through this advanced technology. Robotic Magnetic Navigation brings the benefits of robotic precision and safety to cardiac ablation, a minimally invasive procedure used to treat arrhythmias. Millions of individuals worldwide suffer from arrhythmias, which can lead to serious complications if left untreated, such as stroke, heart failure, and sudden cardiac arrest.
Giuseppe Russo, General Manager of Hospital Santa Maria della Pietà, highlighted the hospital’s commitment to providing the highest standard of care to patients through the adoption of the Genesis system. Luigi Caliendo, Chief of the Cardiology Department at the hospital emphasized their pride in revolutionizing cardiac treatment in Italy with innovative robotic technology.
David Fischel, Stereotaxis Chairman and CEO expressed gratitude for the partnership with Hospital Santa Maria della Pietà in bringing
